79 related articles for article (PubMed ID: 9217010)
1. COS-1 cell expression and one-step affinity protein purification and activity of epitope-tagged human erythropoietin and of site-directed mutants.
Bill RM; Flitsch SL; Bicknell R
Biochim Biophys Acta; 1997 Jun; 1340(1):13-20. PubMed ID: 9217010
[TBL] [Abstract][Full Text] [Related]
2. Selective in vitro glycosylation of recombinant proteins: semi-synthesis of novel homogeneous glycoforms of human erythropoietin.
Macmillan D; Bill RM; Sage KA; Fern D; Flitsch SL
Chem Biol; 2001 Feb; 8(2):133-45. PubMed ID: 11251288
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutagenesis of recombinant human and murine erythropoietins in Escherichia coli.
Bill RM; Winter PC; McHale CM; Hodges VM; Elder GE; Caley J; Flitsch SL; Bicknell R; Lappin TR
Biochim Biophys Acta; 1995 Mar; 1261(1):35-43. PubMed ID: 7893759
[TBL] [Abstract][Full Text] [Related]
4. Role of N-linked glycosylation on the function and expression of the human secretin receptor.
Pang RT; Ng SS; Cheng CH; Holtmann MH; Miller LJ; Chow BK
Endocrinology; 1999 Nov; 140(11):5102-11. PubMed ID: 10537138
[TBL] [Abstract][Full Text] [Related]
5. Structural role of amino acids 99-110 in recombinant human erythropoietin.
Chern YJ; Chung TW; Sytkowski AJ
Eur J Biochem; 1991 Dec; 202(2):225-9. PubMed ID: 1761028
[TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships of the erythropoietin molecule.
Lappin TR; Winter PC; Elder GE; McHale CM; Hodges VH; Bridges JM
Ann N Y Acad Sci; 1994 Apr; 718():191-201; discussion 201-2. PubMed ID: 8185227
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis disrupts posttranslational processing of the Na,K-ATPase catalytic subunit.
Petrosian SA; Carr DL; Guerrero G; Pressley TA
Arch Biochem Biophys; 1998 Sep; 357(2):249-58. PubMed ID: 9735165
[TBL] [Abstract][Full Text] [Related]
9. Site-specific antibodies to human erythropoietin: immunoaffinity purification of urinary and recombinant hormone.
Wojchowski DM; Sue JM; Sytkowski AJ
Biochim Biophys Acta; 1987 Jun; 913(2):170-8. PubMed ID: 2439124
[TBL] [Abstract][Full Text] [Related]
10. Soluble expression and partial purification of recombinant human erythropoietin from E. coli.
Jeong TH; Son YJ; Ryu HB; Koo BK; Jeong SM; Hoang P; Do BH; Song JA; Chong SH; Robinson RC; Choe H
Protein Expr Purif; 2014 Mar; 95():211-8. PubMed ID: 24412408
[TBL] [Abstract][Full Text] [Related]
11. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties.
Yamaguchi K; Akai K; Kawanishi G; Ueda M; Masuda S; Sasaki R
J Biol Chem; 1991 Oct; 266(30):20434-9. PubMed ID: 1657925
[TBL] [Abstract][Full Text] [Related]
12. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
Bhowmick N; Huang J; Puett D; Isaacs NW; Lapthorn AJ
Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Human Erythropoietin with Additional Processable Protein Domains: Purification of Protein Synthesized in Escherichia coli Heterologous Expression System.
Grunina TM; Demidenko AV; Lyaschuk AM; Poponova MS; Galushkina ZM; Soboleva LA; Cherepushkin SA; Polyakov NB; Grumov DA; Solovyev AI; Zhukhovitsky VG; Boksha IS; Subbotina ME; Gromov AV; Lunin VG; Karyagina AS
Biochemistry (Mosc); 2017 Nov; 82(11):1285-1294. PubMed ID: 29223155
[TBL] [Abstract][Full Text] [Related]
14. Structural and biological properties of erythropoietin in Xenopus laevis.
Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T
Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733
[TBL] [Abstract][Full Text] [Related]
15. High-level expression and purification of a recombinant human erythropoietin produced using a baculovirus vector.
Quelle FW; Caslake LF; Burkert RE; Wojchowski DM
Blood; 1989 Aug; 74(2):652-7. PubMed ID: 2752139
[TBL] [Abstract][Full Text] [Related]
16. Secretory production of erythropoietin and the extracellular domain of the erythropoietin receptor by Bacillus brevis: affinity purification and characterization.
Nagao M; Inoue K; Moon SK; Masuda S; Takagi H; Udaka S; Sasaki R
Biosci Biotechnol Biochem; 1997 Apr; 61(4):670-4. PubMed ID: 9145527
[TBL] [Abstract][Full Text] [Related]
17. Utilizing the C-terminal cleavage activity of a protein splicing element to purify recombinant proteins in a single chromatographic step.
Chong S; Montello GE; Zhang A; Cantor EJ; Liao W; Xu MQ; Benner J
Nucleic Acids Res; 1998 Nov; 26(22):5109-15. PubMed ID: 9801307
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation.
Falck D; Haberger M; Plomp R; Hook M; Bulau P; Wuhrer M; Reusch D
Sci Rep; 2017 Jul; 7(1):5324. PubMed ID: 28706253
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.
Deslauriers B; Ponce C; Lombard C; Larguier R; Bonnafous JC; Marie J
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):397-405. PubMed ID: 10191272
[TBL] [Abstract][Full Text] [Related]
20. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
Van Antwerp ME; Chen DG; Chang C; Prochownik EV
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
